Acta Oncol

1. HE C, Li F, He M, Li J, et al
   The false-negative rate of sentinel lymph node biopsy and its related factors in early-stage cervical cancer: a systematic review and meta-analysis.
   Acta Oncol. 2026;65:213-227.
   

   >> Share

   
   

   
   AIDS Behav

2. SCHNALL R, Ozoria Ramirez S, Halpern M, Kuhn L, et al
   Factors Related To Improving the Quality of Cervical Cancer Screening for Women Living with HIV in La Romana, Dominican Republic: A Qualitative Descriptive Study.
   AIDS Behav. 2026 Mar 14. doi: 10.1007/s10461-026-05074.
   

   >> Share

   
   

   
   Am Fam Physician

3. WISER A MD, Quinlan JD MD
   Cervical Cancer Screening.
   Am Fam Physician. 2026;113:137-144.
   

   >> Share

   
   
4. 
   Self-Collected Samples for Cervical Cancer Screening: What You Need to Know.
   Am Fam Physician. 2026;113:online.
   

   >> Share

   
   

   
   Appl Opt

5. CHANDA S, Kumar N, Agarwal A, Pradhan A, et al
   Fluorescence Mueller matrix imaging of the stromal region in unstained cervical tissue sections: quantitative categorization of CIN grades.
   Appl Opt. 2025;64:8840-8848.
   

   >> Share

   
   

   
   Arch Iran Med

6. NEZAMABADI FARAHANI L, Kazemnejad A, Afrasiabi M, Tapak L, et al
   In Silico Transcriptomic Analysis for Identification of Potential Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer using a Hybrid Genetic Algorithm-Support Vector Machine Approach.
   Arch Iran Med. 2025;28:677-686.
   

   >> Share

   
   

   
   BMC Cancer

7. CHHOKAR A, Joshi U, Keshavam CC, Gupta B, et al
   Development of a novel multi-locus Flow-FISH based assay for detection of progressive cervical precancer lesions.
   BMC Cancer. 2026;26:343.
   

   >> Share

   
   

   
   BMC Complement Med Ther

8. RADHAKRISHNAN M, Parida BP, Shekhar H, Singh P, et al
   Anticancer potential of Curcuma caesia: induction of DNA damage and apoptosis in cervical cancer.
   BMC Complement Med Ther. 2026 Mar 21. doi: 10.1186/s12906-026-05351.
   

   >> Share

   
   
9. ASAKITOGUM DA, Ohene LA, Aziato L
   Women's experiences with traditional medicine for the treatment of cervical cancer: a qualitative study.
   BMC Complement Med Ther. 2026 Mar 13. doi: 10.1186/s12906-026-05344.
   

   >> Share

   
   
10. LAGU IJL, Letoluo R, Kamau SW, Kuria JM, et al
    Antiproliferative activity, phytochemistry, network pharmacology, molecular docking and gene expression analysis of Maerua edulis extracts against human cervical cancer cell line.
    BMC Complement Med Ther. 2026 Mar 14. doi: 10.1186/s12906-026-05321.
    

    >> Share

    
    

    
    BMC Res Notes

11. MUTISYA R, Gitonga E, Maundu MM, Iseme-Ondiek R, et al
    Implementation and acceptability of a community based intervention for cervical cancer screening amongst women of reproductive age in Kiambu County, Kenya.
    BMC Res Notes. 2026 Mar 15. doi: 10.1186/s13104-026-07710.
    

    >> Share

    
    

    
    BMC Womens Health

12. NAVAKANITWORAKUL R, Choochuen P, Hanprasertpong J, Liangpunsakul S, et al
    Plasma proteomic biomarkers for predicting chemoradiation response in locally advanced cervical cancer.
    BMC Womens Health. 2026 Mar 19. doi: 10.1186/s12905-026-04410.
    

    >> Share

    
    

    
    BMJ Glob Health

13. DUN C, Su Y, Basu P, Zhao X, et al
    Temporal trends in cervical cancer incidence and mortality in economically emerging countries, 1992-2021: an age-period-cohort analysis.
    BMJ Glob Health. 2026;11:e018569.
    

    >> Share

    
    

    
    Cancer Epidemiol

14. QI M, Tian C, Di X, Ma J, et al
    Trends and regional patterns of cervical cancer incidence by histological subtypes: A Chinese population-based analysis from cancer registry data.
    Cancer Epidemiol. 2026;102:103047.
    

    >> Share

    
    

    
    Cancer Res

15. SANDOVAL TA, Li Y, Muhammad N, Desai T, et al
    Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.
    Cancer Res. 2026 Mar 20:OF1-OF18. doi: 10.1158/0008-5472.CAN-25-3776.
    

    >> Share

    
    

    
    Cancers (Basel)

16. SHENG Y, Wujcik HE, Wakefield MR, Fang Y, et al
    Poseidon's Trident: "Divine" Intervention in Cervical Cancer Through Chemoradiation, Immunotherapy, and Antibody-Drug Conjugates.
    Cancers (Basel). 2026;18:774.
    

    >> Share

    
    
17. CHANG Y, Kay N, Chiu LC, Huang CI, et al
    Incidence Trends and Geographic Variations of Corpus Uteri and Cervical Cancer in Taiwan, 1995-2022: A Population-Based Study.
    Cancers (Basel). 2026;18:881.
    

    >> Share

    
    
18. LIU J, Zhu Y, Liu K, Deng D, et al
    Comprehensive Comparison of Surgery Followed by Radiotherapy and Radical Radiotherapy for Cervical Cancer: A Multicenter Retrospective Propensity-Score-Matched Analysis.
    Cancers (Basel). 2026;18:865.
    

    >> Share

    
    

    
    Cell Death Discov

19. SUN R, Gong H, Zhao R, Lv H, et al
    SOX4 induces cisplatin resistance in cervical cancer cells by inhibiting aerobic glycolysis.
    Cell Death Discov. 2026 Mar 14. doi: 10.1038/s41420-026-02954.
    

    >> Share

    
    

    
    Ceska Gynekol

20. ROKOS T, Kudela E, Pribulova T, Holubekova V, et al
    Cytological versus histological results in ASCUS cervical dysplasia - a retrospective study.
    Ceska Gynekol. 2026;91:11-15.
    

    >> Share

    
    
21. ROBOVA K, Pichlik T, Rob L, Robova H, et al
    Age-specific incidence and mortality of cervical cancer in the Czech Republic - analysis of nationwide data and data from a gynecologic oncology center.
    Ceska Gynekol. 2026;91:61-68.
    

    >> Share

    
    
22. JANOVSKA N, Rob L, Pichlik T, Sehnal B, et al
    Cervical cancer screening in the European context - from cytology to primary HPV testing.
    Ceska Gynekol. 2026;91:69-76.
    

    >> Share

    
    

    
    Cureus

23. BELCHER NL
    Clinician Education and Workflow Tools to Improve Access to Recurrent and Metastatic Cervical Cancer Treatment.
    Cureus. 2026;18:e103426.
    

    >> Share

    
    

    
    Curr Cancer Drug Targets

24. MARTIN RJ, Arya M, Ramakrishnan J, Menachery SJ, et al
    Machine Vision Approaches for Cervical Cancer Screening Using Pap-Smear Images: A Systematic Review.
    Curr Cancer Drug Targets. 2026 Mar 11. doi: 10.2174/0115680096398033251128082310
    

    >> Share

    
    

    
    Curr Protoc

25. CHAN HCC, Bhoora S, Zhou E, Marais S, et al
    Analysis of Reactive Oxygen Species-Induced Cellular Damage in Cervical Cancer.
    Curr Protoc. 2026;6:e70328.
    

    >> Share

    
    

    
    Data Brief

26. OGUNLAJA AO, Adeleke OT, Ughonu PC, Oyelami MO, et al
    A multi-magnification digital colposcopy image datasets for cervical cancer screening in Nigeria.
    Data Brief. 2026;65:112633.
    

    >> Share

    
    

    
    Dose Response

27. YANG X, Zhao B, Yu G, He Z, et al
    Dosimetric Comparison of Intracavitary Versus Combined Intracavitary-Interstitial Image-Guided Brachytherapy in Locally Advanced Cervical Cancer.
    Dose Response. 2026;24:15593258261430575.
    

    >> Share

    
    

    
    Front Med (Lausanne)

28. BAUTISTA J, Cortinas Sardi P, Paguay-Caisabanda I, Gancino-Guevara K, et al
    Integrating microbiome insights into cervical cancer.
    Front Med (Lausanne). 2026;13:1766052.
    

    >> Share

    
    

    
    Front Oncol

29. YANG W, Lu J, Wang L, Wang H, et al
    Dosimetric comparison of MRI-guided and CT-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer.
    Front Oncol. 2026;16:1765505.
    

    >> Share

    
    
30. XIAO C, Zeng S, Li L, Wang R, et al
    Sentinel lymph node biopsy versus lymphadenectomy in early-stage cervical cancer: a meta-analysis of oncologic outcomes and surgical morbidity.
    Front Oncol. 2026;16:1765529.
    

    >> Share

    
    

    
    Front Pharmacol

31. XIAO C, Zeng S, Li L, Wang R, et al
    Efficacy and safety of immune checkpoint inhibitors combined with chemoradiotherapy in locally advanced cervical cancer: a systematic review and meta-analysis.
    Front Pharmacol. 2026;17:1766157.
    

    >> Share

    
    

    
    Gynecol Oncol

32. SAAB R, Brazan A, Chisholm GB, Gonzales NR, et al
    Clear cell carcinoma of cervix and vagina: A review of 63 cases in the post-DES era.
    Gynecol Oncol. 2026;206:39-44.
    

    >> Share

    
    

    
    HIV Med

33. NDLELA MG, Vilakati LN, Williams V, Ginindza NM, et al
    Cervical cancer screening adherence following initial HIV testing in Eswatini.
    HIV Med. 2026 Mar 19. doi: 10.1111/hiv.70227.
    

    >> Share

    
    

    
    Hum Cell

34. WEI X, Su L, Chen R, He T, et al
    Unveiling TNFRSF19: a novel tumor suppressor targeting endoplasmic reticulum stress and LGR5/Wnt/beta-catenin in cervical cancer.
    Hum Cell. 2026;39:53.
    

    >> Share

    
    

    
    Hum Vaccin Immunother

35. JIA X, Da X, Shi J, Duan R, et al
    HPV vaccine awareness and uptake among women attending cervical screening in health-resource-limited areas of China: A multicenter cross-sectional study.
    Hum Vaccin Immunother. 2026;22:2644020.
    

    >> Share

    
    
36. PARELLADA CI, Bierrenbach AL, Bittencourt Campaner A, Goncalves Queijo R, et al
    Assessing the burden of HPV-associated cancers in Brazil: Hospitalization and mortality trends from 2011 to 2019.
    Hum Vaccin Immunother. 2026;22:2640760.
    

    >> Share

    
    

    
    Int J Biol Macromol

37. CHEN Y, Zhong L, Chen J, Li X, et al
    Corrigendum to "Glutamine modified lipid nanoparticles loaded with GPX4 siRNA for cervical cancer targeting" [Int. J. Biol. Macromol. 336 (2026) 149419].
    Int J Biol Macromol. 2026 Mar 13:151353. doi: 10.1016/j.ijbiomac.2026.151353.
    

    >> Share

    
    
38. XIONG H, Shi X, Li L, Yang Q, et al
    Emodin exerts antitumor effects in cervical cancer cells by reprogramming phospholipid metabolism through modulation of H3K27ac and H3K27me3.
    Int J Biol Macromol. 2026 Mar 17:151454. doi: 10.1016/j.ijbiomac.2026.151454.
    

    >> Share

    
    

    
    Int J Cancer

39. HU Y, Liu Y, Guo W, Hong Z, et al
    Efficacy and safety of 5-aminolevulinic acid-based photodynamic therapy for cervical low-grade squamous intraepithelial lesions with HPV infections.
    Int J Cancer. 2025 Dec 8. doi: 10.1002/ijc.70273.
    

    >> Share

    
    
40. ELFSTROM KM, Hortlund M, Ohman D, Dillner J, et al
    Cancer detection using human papillomavirus self-sampling targeting long-term non-attenders in an organized cervical screening program.
    Int J Cancer. 2026;158:2729-2735.
    

    >> Share

    
    
41. QUAN J, Chen Q, Lan L, Zhang B, et al
    Type- and age-specific natural history of high-risk human papillomavirus infections in healthy women: A prospective cohort study in China.
    Int J Cancer. 2026;158:2736-2746.
    

    >> Share

    
    

    
    Int J Gen Med

42. LIU W, Niu Z, Yan Z, Shi L, et al
    The Association of EGFL7 Polymorphism and Expression with Cervical Cancer Susceptibility and Pathogenesis.
    Int J Gen Med. 2026;19:563592.
    

    >> Share

    
    

    
    Int J Gynaecol Obstet

43. LIU X, Lyu Q, Li X, He L, et al
    Interaction between the level of human papillomavirus integration and human papillomavirus type on the risk of grade 3 cervical intraepithelial neoplasia or more severe in human papillomavirus integration positive women: A cross-sectional study.
    Int J Gynaecol Obstet. 2026;173:187-195.
    

    >> Share

    
    
44. MOEIN S, Romo FAL, Fischel LB, Singh N, et al
    Fluorescein colposcopy-A more specific diagnostic method for detection of high-grade cervical precancer lesions than acetic acid.
    Int J Gynaecol Obstet. 2026;173:138-143.
    

    >> Share

    
    
45. GULHAN I, Orun H, Yanigli G, Cagiran RN, et al
    Human papillomavirus positivity and cervical intraepithelial lesion in cervical biopsy and endocervical curettage in women younger than 30 years.
    Int J Gynaecol Obstet. 2026;173:209-215.
    

    >> Share

    
    
46. HO QN, Quang Le T, Pham AHT, Nguyen PN, et al
    Efficacy of thermal ablation among women with cervical intraepithelial neoplasia grade 1 and high-risk human papillomavirus genotypes: The first prospective study in Vietnam.
    Int J Gynaecol Obstet. 2026;173:411-421.
    

    >> Share

    
    

    
    Int J Mol Sci

47. SOHEL HI, Zahan UF, Ishikawa M, Kanno K, et al
    Integrated Molecular and Functional Characterization of Cervical Small-Cell Neuroendocrine Carcinoma Using a 3D Organoid Model.
    Int J Mol Sci. 2026;27:2393.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

48. GULSTENE S, Chuk E, Conway J, Hanuschak J, et al
    Dosimetric predictors of sexual toxicity in cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy.
    Int J Radiat Oncol Biol Phys. 2026 Mar 18:S0360-3016(26)00505.
    

    >> Share

    
    

    
    Int J Surg Case Rep

49. DORJI C, Dorji N, Dechen S, Pradhan G, et al
    Incidental finding of a sewing needle in the buttock of a woman with cervical cancer: how did we manage it?
    Int J Surg Case Rep. 2026;138:808-813.
    

    >> Share

    
    

    
    Int J Womens Health

50. HOMENTA C, Kurniadi A, Winarno GNA, Santiana L, et al
    Neoadjuvant Paclitaxel-Carboplatin Followed by Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer.
    Int J Womens Health. 2026;18:580324.
    

    >> Share

    
    

    
    J Am Assoc Nurse Pract

51. TOLOSKO J, Beauchesne M
    A comparison of the knowledge and practices of cervical cancer prevention between United States and international female college students.
    J Am Assoc Nurse Pract. 2026 Mar 20. doi: 10.1097/JXX.0000000000001272.
    

    >> Share

    
    

    
    J Am Soc Cytopathol

52. ROTH MT, Torous VF
    Cytomorphologic alterations, histologic correlates, and clinical importance of pap test evaluation in intrauterine device users.
    J Am Soc Cytopathol. 2026;15:133-143.
    

    >> Share

    
    

    
    J Bioenerg Biomembr

53. KURBAN R, Pan J, Amar T, Bo X, et al
    The eIF3a/m6A/ENO1 axis orchestrates glycolytic reprogramming and cell growth in cervical cancer.
    J Bioenerg Biomembr. 2026 Mar 18. doi: 10.1007/s10863-026-10096.
    

    >> Share

    
    

    
    J Cancer Educ

54. WILLIAMS KP, Todem D, Roman LA, Meghea CI, et al
    Kin Keeper(SM) Breast and Cervical Cancer Prevention: An Educational Intervention: A Community-Based Randomized Controlled Trial in Black, Latina, and Arab Women.
    J Cancer Educ. 2026 Mar 20. doi: 10.1007/s13187-026-02851.
    

    >> Share

    
    

    
    J Clin Microbiol

55. MANJESHWAR S, Kojima N, Tsang E, Pereira D, et al
    Reply to "Urine-based detection of HPV for cervical cancer screening: towards clinical implementation".
    J Clin Microbiol. 2026 Mar 16:e0016226. doi: 10.1128/jcm.00162.
    

    >> Share

    
    
56. LI G, Lamsisi M, Chenafi S, Moniod L, et al
    Urine-based detection of HPV for cervical cancer screening: towards clinical implementation.
    J Clin Microbiol. 2026 Mar 16:e0013326. doi: 10.1128/jcm.00133.
    

    >> Share

    
    

    
    J Egypt Natl Canc Inst

57. LU Z, Li Y, Luo D, Chen C, et al
    Impact of bladder volume precision control on setup errors and dosimetry in intensity-modulated radiation therapy for cervical cancer.
    J Egypt Natl Canc Inst. 2026;38:9.
    

    >> Share

    
    

    
    J Gynecol Oncol

58. KIM JH, Shim SH, Min KJ, Lee JK, et al
    Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology.
    J Gynecol Oncol. 2026 Mar 1. doi: 10.3802/jgo.2026.
    

    >> Share

    
    

    
    J Low Genit Tract Dis

59. UYSAL O, Yalcin Y, Cakar MK, Ozerkan K, et al
    The Effect of Cervical Blockade in LEEP Procedures Performed Under General Anesthesia: A Randomized Controlled Trial.
    J Low Genit Tract Dis. 2026;30:132-139.
    

    >> Share

    
    
60. CAI C, Richards-McDonald L, Trimble CL
    Barriers to Cervical Cancer Screening Follow-up: A Study of an Inpatient Screening Program.
    J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000943.
    

    >> Share

    
    
61. BOOTH BB, Khare SK, Blanes-Vidal V, Bor P, et al
    Higher Diagnostic Accuracy of an AI Model for Colposcopy Compared With Conventional and Digital Colposcopic Evaluation.
    J Low Genit Tract Dis. 2026;30:118-123.
    

    >> Share

    
    
62. CHEN CC, Hsiao KY, Lu SC, Bai CH, et al
    Accuracy of HPV Testing Using Self-collected Urine Compared With Physician-collected Cervical Specimen for HSIL or Worse.
    J Low Genit Tract Dis. 2026;30:100-109.
    

    >> Share

    
    
63. KETCH PW, Boitano TKL, Longinos NA, Swann SA, et al
    Physician Perspectives on the Transition to Primary Human Papillomavirus Testing for Cervical Cancer Screening.
    J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000942.
    

    >> Share

    
    
64. DANIELS K, Khan MJ, Gaffikin L, Gonzalez Montoya RA, et al
    Integrating Cervical Cancer Screening Into Pre-existing, Low-resource Mexican-US Border Clinics.
    J Low Genit Tract Dis. 2026 Mar 16. doi: 10.1097/LGT.0000000000000940.
    

    >> Share

    
    

    
    J Med Internet Res

65. JI L, Zhou X, Yao L
    Factors Influencing Universal Coverage of AI-Assisted Cervical Cancer Screening: A Qualitative Study Based the Macro Model of Health System.
    J Med Internet Res. 2026 Feb 23. doi: 10.2196/75372.
    

    >> Share

    
    

    
    J Obstet Gynaecol Can

66. GE Y, Wang X, Zhang Y, Ma L, et al
    Comparative Survival Outcomes of Total Hysterectomy Versus Radical Hysterectomy in Gastric-Type Endocervical Adenocarcinoma: A SEER Database Analysis.
    J Obstet Gynaecol Can. 2026;48:103156.
    

    >> Share

    
    

    
    J Obstet Gynaecol Res

67. HALDER S, Singh S, Sood R, Mathur S, et al
    Synchronous Presentation of Gastric-Type Adenocarcinoma In Situ of Cervix and Vagina in a Young Adult Female: A Precursor Seldom Seen.
    J Obstet Gynaecol Res. 2026;52:e70249.
    

    >> Share

    
    

    
    J Pak Med Assoc

68. OZDEMIR S, Caglayan R
    Health education on HPV vaccination and cervical cancer prevention: A randomised controlled trial on knowledge, attitudes, beliefs, and behaviours.
    J Pak Med Assoc. 2026;76:140-150.
    

    >> Share

    
    

    
    J Pharm Bioallied Sci

69. KUMAR N, Dash M, Lal P, Kotian T, et al
    Incidence and Impact of HPV Vaccination on Cervical Cancer: A Data Base Research.
    J Pharm Bioallied Sci. 2025;17.
    

    >> Share

    
    
70. AMATULLAH M, Begum SA, Mahmud T, Nahar K, et al
    Association of Preoperative Controlling Nutritional Status (CONUT) Score with the Staging of Cervical Cancer.
    J Pharm Bioallied Sci. 2025;17.
    

    >> Share

    
    
71. PUROBI SM, Ashrafunnesa, Begum SA, Mahmud T, et al
    HPV DNA Test Alone and HPV DNA Test Combined with VIA as Screening Test for Cervical Cancer.
    J Pharm Bioallied Sci. 2026;18.
    

    >> Share

    
    

    
    J Prim Care Community Health

72. DELGADO LOPEZ D, Pozo-Palacios J, Vergara Quezada J, Caulier-Cisterna R, et al
    Factors Associated with Under- and Over-Screening for Cervical Cancer in Rural Areas of Cuenca, Ecuador.
    J Prim Care Community Health. 2026;17:21501319251414282.
    

    >> Share

    
    

    
    J Transcult Nurs

73. KOZACHEK CC, Btoush R
    Cervical Cancer Risk: Sexual and Screening Behaviors Among Middle Eastern College Women in the United States.
    J Transcult Nurs. 2026 Mar 17:10436596261430095. doi: 10.1177/10436596261430095.
    

    >> Share

    
    

    
    J Transl Med

74. WANG Y, Qiao H, Yu P, Gao W, et al
    IKBIP as a prognostic biomarker and immunotherapeutic target regulates the JAK-STAT3 signaling pathway to promote cervical cancer.
    J Transl Med. 2026 Mar 20. doi: 10.1186/s12967-026-08015.
    

    >> Share

    
    

    
    J Womens Health (Larchmt)

75. BOLTEN K, Burns H, Scott C, Smart K, et al
    Cytology and High-Risk Human Papillomavirus Testing Performance for Cervical Cancer Screening in Transmasculine Patients.
    J Womens Health (Larchmt). 2026 Mar 18:15409996261433761.
    

    >> Share

    
    

    
    JCO Glob Oncol

76. BARAL S, Silwal SR, Bhattarai N, Lamichhane D, et al
    Evaluation of Quality Indicators for Radiation Therapy of Cervical Cancer: Experience From a Tertiary Cancer Center in Nepal.
    JCO Glob Oncol. 2026;12:e2500435.
    

    >> Share

    
    
77. JACOBS C, DeMoulin D, Kayamba V, Sudenga S, et al
    Stigma and Its Association With Social Support and Quality of Life Among Patients With Cervical Cancer in Zambia.
    JCO Glob Oncol. 2026;12:e2500593.
    

    >> Share

    
    

    
    Jpn J Clin Oncol

78. WATANABE K, Di Carlo V, Sugiyama H, Nakamura S, et al
    Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).
    Jpn J Clin Oncol. 2026;56.
    

    >> Share

    
    

    
    Mol Cell Biochem

79. YANG D, Liu J, Gao Y, Guan X, et al
    RNF125 promotes CD8 T cell-mediated anticancer immunity and suppresses the malignant phenotype of cervical cancer.
    Mol Cell Biochem. 2026 Mar 13. doi: 10.1007/s11010-026-05507.
    

    >> Share

    
    

    
    Nat Commun

80. SUN Y, Yang H, Wang J, Lou H, et al
    Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.
    Nat Commun. 2026 Mar 14. doi: 10.1038/s41467-026-69965.
    

    >> Share

    
    
81. OSAFO KS, Zhang Y, Obiri-Yeboah D, Sun B, et al
    Advancing the elimination of cervical cancer across Africa.
    Nat Commun. 2026 Mar 13. doi: 10.1038/s41467-026-70450.
    

    >> Share

    
    

    
    NPJ Digit Med

82. ZHU Y, Wang H, Zhang B, Chen M, et al
    Trends in over- and under-screening for cervical cancer after EMR implementation in rural China.
    NPJ Digit Med. 2026 Mar 20. doi: 10.1038/s41746-026-02504.
    

    >> Share

    
    

    
    Obstet Gynecol Sci

83. WANGSATIDTONGBAI P, Buhachat R, Thiangphak E
    Three-year post-recurrence survival outcome by leukopenia grade 2+ during systemic chemotherapy in recurrent cervical cancer.
    Obstet Gynecol Sci. 2026 Mar 17. doi: 10.5468/ogs.26032.
    

    >> Share

    
    

    
    Oncol Lett

84. LUO J, Li G, Ye M, Xu X, et al
    RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP-9.
    Oncol Lett. 2026;31:165.
    

    >> Share

    
    

    
    PLoS One

85. WU Q, Bai S, Wang P, Han L, et al
    Limonin induces ferroptosis in cervical squamous cell carcinoma by activating the expression of soluble epoxide hydrolase 2 protein.
    PLoS One. 2026;21:e0343495.
    

    >> Share

    
    
86. AFAYA A, Awunyo W, Udeoha MA, Kodjo MM, et al
    The relational association between multiple sexual partners and HIV testing on cervical cancer screening among women of reproductive age in Ghana: A national population-based study.
    PLoS One. 2026;21:e0344086.
    

    >> Share

    
    
87. AYASS MA, Zaman N, Griko N, Pashkov V, et al
    Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions.
    PLoS One. 2026;21:e0339693.
    

    >> Share

    
    

    
    Pract Radiat Oncol

88. MAINA J, Benseler A, Dzyubak O, Bouchard-Fortier G, et al
    Retained Surgical Sponge in the Pelvis From Magnetic Resonance Imaging-Guided Cervix Brachytherapy.
    Pract Radiat Oncol. 2026;16:103-106.
    

    >> Share

    
    

    
    Prev Med

89. EL-ZEIN M, Kassam P, Alhamlan F, Zafar N, et al
    Toward cervical cancer prevention and elimination in the Eastern Mediterranean Region: Current landscape and opportunities for evidence-based action.
    Prev Med. 2026 Mar 16:108549. doi: 10.1016/j.ypmed.2026.108549.
    

    >> Share

    
    

    
    Psychooncology

90. GUILLAUME D, Perrin N, Alcaide ML, Amedee LM, et al
    Development and Psychometric Testing of a Scale Evaluating Traditional Health Practices for Cervical Cancer Prevention Among Haitian Migrant Women.
    Psychooncology. 2026;35:e70433.
    

    >> Share

    
    

    
    Rev Saude Publica

91. ABREU M, Mota ME, Oliveira DMA, Medeiros YL, et al
    Inequalities in time to cancer treatment initiation over a decade in Brazil.
    Rev Saude Publica. 2026;60:e12.
    

    >> Share

    
    

    
    Sci China Life Sci

92. GAO W, Wang C, Jia J, Li Y, et al
    Evaluation and comparison of TCR repertoire differences between patients with cervical cancer and healthy individuals.
    Sci China Life Sci. 2026 Mar 10. doi: 10.1007/s11427-025-3221.
    

    >> Share

    
    

    
    Strahlenther Onkol

93. CILLA S, Medici F, Ferioli M, Arcelli A, et al
    Unsupervised clustering analysis unravels the role of systemic inflammatory indices in the prognosis of patients with locally advanced cervical cancer treated with chemoradiation.
    Strahlenther Onkol. 2026 Mar 17. doi: 10.1007/s00066-026-02513.
    

    >> Share

    
    

    
    Toxicon

94. OSORNO-VALENCIA D, Montoya-Gomez A, Sevilla-Sanchez MJ, Burbano-Guerrero N, et al
    Lansbermin-I, a disintegrin from Porthidium lansbergii lansbergii venom as a potential anticancer prototype: In vitro and in silico effects on cervical cancer cells.
    Toxicon. 2026;276:109063.
    

    >> Share

    
    

    
    Tunis Med

95. BELHADJ A, Boumeddane YK, Meddah D, Sahraoui T, et al
    Exploring risk factors and survival rates in invasive cervical carcinoma: New perspectives.
    Tunis Med. 2025;103:1098-1103.
    

    >> Share

    
    

    
    Vaccine

96. LU Y, Tang C, Xu S, Hussain I, et al
    Understanding parental HPV vaccination decision in China through the lens of vaccine hesitancy and preference heterogeneity: a discrete choice experiment.
    Vaccine. 2026;76:128307.
    

    >> Share

    
    
97. LIXIA H, Liangcheng X, Tian T, Dongmei Z, et al
    Prevalence of high-risk human papillomavirus among women with different HPV-vaccination status in Sichuan, China.
    Vaccine. 2026;77:128387.
    

    >> Share

    
    

    
    Virchows Arch

98. SHEN P, Ye J, Yee HN, Zhang L, et al
    Prognostic significance of tumor budding and residual viable tumor volume in post-neoadjuvant resection specimens of locally advanced cervical cancer.
    Virchows Arch. 2026 Mar 20. doi: 10.1007/s00428-026-04477.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share